FORSYTH DOUGLAS purchased 50.1% of their position (75K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $1.04M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/26/2024ACC: 0002007919-24-000040
+75K
Net shares
Net buyer
$1.04M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
75K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+15.19K
Price / share
$12.89
Trade value
$195.77K
% of position
10.2%
8/22/2024
149.56K→164.75K
Common Stock
Indirect
Shares
+59.81K
Price / share
$14.07
Trade value
$841.55K
% of position
36.3%
8/23/2024
164.75K→224.56K
Total
Net shares
+75K
Net value
$1.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/22/2024 | P · Purchase | +15.19K | $12.89 | $195.77K | 10.2% | 149.56K | 164.75K |
| Common Stock Indirect | 8/23/2024 | P · Purchase | +59.81K | $14.07 | $841.55K | 36.3% | 164.75K | 224.56K |
| Total | +75K | $1.04M | ||||||
Derivative Transactions0
No derivative transactions reported